TY - JOUR AU - Weiss, Günter PY - 2013 TI - Erythropoietin and cancer - a poorly understood liaison! JF - Chinese Clinical Oncology; Vol 1, No 2 (December 01, 2012): Chinese Clinical Oncology Y2 - 2013 KW - N2 - Human recombinant erythropoietin (rhEpo) has been used for many years to treat chemotherapy and cancer associated anemia. The application of rhEpo resulted in an improved quality of life of patients and in a sparing of blood transfusions (1). UR - https://cco.amegroups.org/article/view/1354